suvaxyn parvo/e - amphigen
zoetis belgium sa, belgia - parvovirus porcin inactivat, tulpina s-80, erysipelothrix rhusiopathiae, inactivat, tulpina b-7 (serotip 2) - emulsie injectabilă - produse biologice - porcine - porci imunizarea activă pentru prevenirea tulburărilor reproductive cauzate de parvovirusul porcin, reducerea semnelor clinice cauzate de infecţiile cu erysipelothrix rhusiopathiae, serotipul 2 şi serotipul 1.
suvaxyn circo
zoetis belgium sa, belgia - circovirus - emulsie injectabilă
suvaxyn circo+mh rtu
zoetis belgium sa, belgia - circovirus - emulsie injectabilă
suvaxyn prrs mlv
zoetis belgium s.a., belgia - vprrs-1 - liofilizat şi solvent pentru suspensie injectabilă
vaccin, suvaxyn mhps parasuis
srl zoofarmagro - vaccin - suine
vaccin, suvaxyn pcv-2,
srl zoofarmagro - vaccin - suine
circomax myco
zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunologii pentru suidae - porci (pentru îngrășare) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.